Jalayne J. Arias, JD, MA and Kathryn L. Weise, MD, MA
Even when external factors such as nonaccidental injury weigh heavily on clinicians' perceptions, they should not lose focus on the patient's best interest when deciding whether to continue or withdraw treatment.
David Elkin, MD, Erick Hung, MD, and Gilbert Villela, MD
The rapidly evolving field of neuroethics is concerned with the ethical questions that new technologies will pose about autonomy, privacy, the definition of normal, and individuality.
Informed assent, in which the family or surrogate decision makers for a patient are invited to defer to clinicians' judgment rather than specifically consenting to withholding or withdrawing futile treatments, is consistent with quality care and may protect surrogates from feeling responsible for the patient’s death.
Balancing parents' rights to raise their children and a state's duty to protect children is no easy task. Even though most states have religious exemptions to child abuse or neglect laws, courts have ruled in favor of both parents and states, depending on the circumstances.
This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.